Reduced graphene oxide-metalloporphyrin sensors for human breath screening

16Citations
Citations of this article
25Readers
Mendeley users who have this article in their library.

Abstract

The objective of this study is to validate reduced graphene oxide (RGO)-based volatile organic compounds (VOC) sensors, assembled by simple and low-cost manufacturing, for the detection of disease-related VOCs in human breath using machine learning (ML) algorithms. RGO films were functionalized by four different metalloporphryins to assemble cross-sensitive chemiresistive sensors with different sensing properties. This work demonstrated how different ML algorithms affect the discrimination capabilities of RGO–based VOC sensors. In addition, an ML-based disease classifier was derived to discriminate healthy vs. unhealthy individuals based on breath sample data. The results show that our ML models could predict the presence of disease-related VOC compounds of interest with a minimum accuracy and F1-score of 91.7% and 83.3%, respectively, and discriminate chronic kidney disease breath with a high accuracy, 91.7%.

Cite

CITATION STYLE

APA

Lee, B. M., Eetemadi, A., & Tagkopoulos, I. (2021). Reduced graphene oxide-metalloporphyrin sensors for human breath screening. Applied Sciences (Switzerland), 11(23). https://doi.org/10.3390/app112311290

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free